Program
The Hepatologist’s Perspective (Prof. Hannes Hagström)
-
Importance of fibrosis in MASLD risk assessment
-
Non-invasive tools like LSM by VCTE™ to stage disease and help predict clinical outcomes
The Endocrinologist’s Perspective (Prof. Stefano Romeo)
-
Managing MASLD in patients with Type 2 Diabetes – how to identify at-risk patients?
- Addressing hypolipidemia & hypertriglyceridemia
Real-life clinical cases, followed by a question-and-answer session with the speakers.